Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
This randomized controlled trial study aims to evaluate the feasibility and preliminary efficacy of a combined inspiratory muscle training (IMT) and blood flow restriction (BFR) intervention in frail older adults. Outcomes of interest include feasibility, physical function, respiratory muscle strength, handgrip strength, five-times sit-to-stand performance, body composition, frailty level, fall efficacy, blood pressure, and adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
May 7, 2026
May 1, 2026
5 months
April 23, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Recruitment rate
The recruitment rate will be calculated by dividing the number of recruited participants by the number of eligible participants
T0 = baseline; T1 = immediately after intervention
Attrition rate
Attrition rate is the proportion of randomized participants who withdraw from the study or are lost to follow-up before completing the final assessment.
T0 = baseline; T1 = immediately after intervention
Exercise Enjoyment
Enjoyment will be assessed using a single-item Exercise Enjoyment Scale, which asks participants, "How much did you enjoy the exercise session?). Responses are rated on a 7 Likert scale ranging from 1 (not at all) to 7 (extremely)
T0 = baseline; T1 = immediately after intervention
Short Physical Performance Battery (SPPB)
The SPPB consists of three components-standing balance, gait speed, and repeated chair stands-each scored from 0 to 4 and summed to a total score ranging from 0 (worst performance) to 12 (best performance). Lower SPPB scores indicate poorer physical function and a higher risk of adverse outcomes, with scores below 10 predictive of all-cause mortality in older adults.
T0 = baseline; T1 = immediately after intervention
6-Minute Walk Test (6MWT)
The 6MWT will be used to assess functional exercise capacity. Participants will be instructed to walk as far as possible along a flat, straight course for 6 minutes, and the total distance is recorded.
T0 = baseline; T1 = immediately after intervention
Time Up to Go (TUG)
The TUG test is used to assess functional mobility, balance, and fall risk in older adults, incorporating a series of dynamic activities. Participants will be instructed to rise from a chair, walk three meters at a comfortable pace, turn around, walk back to the chair, and sit down. The total time taken to complete the task is recorded, with longer times indicating poorer functional mobility and higher fall risk
T0 = baseline; T1 = immediately after intervention
Secondary Outcomes (8)
Respiratory Muscle Strength
T0 = baseline; T1 = immediately after intervention
Handgrip Strength
T0 = baseline; T1 = immediately after intervention
Five-times sit-to-stand
T0 = baseline; T1 = immediately after intervention
Frailty level
T0 = baseline; T1 = immediately after intervention
Fall Efficacy
T0 = baseline; T1 = immediately after intervention
- +3 more secondary outcomes
Other Outcomes (2)
The Borg Rating of Perceived Exertion (RPE) Scale
T0 = baseline; T1 = immediately after intervention
Automated Office Blood Pressure
T0 = baseline; T1 = immediately after intervention
Study Arms (2)
Intervention group
EXPERIMENTALParticipants in the experimental group will receive a 6 week combined BFR and IMT intervention
Control group
SHAM COMPARATORParticipants in the control group will receive a 6-week combined combined BFR and sham IMT intervention.
Interventions
Each session will last approximately 60 minutes and will include three components: (1) an initial 3-minute IMT exercise performed at an intensity corresponding to rating of perceived exertion (RPE) 11-13 on the Borg 6-20 scale, (2) a 50-minute low-intensity exercise program combined with BFR, and (3) a second 3-minute IMT session at the same target intensity. For the IMT, the protocol follows a progressive intensity model, starting with 30% of the maximum inspiratory pressure (MIP) in Week 1 to allow participants to become familiar with the technique. The intensity will gradually increase to a target of 60% MIP by Week 6, based on the participants' tolerance. For the BFR, during weeks 1-2, participants will train at constant loads. From weeks 2-6, training loads will be increased. Cuff pressure will be prescribed relative to the calculated arterial occlusion pressure (AOP): 50% in weeks 1-2, 60% in weeks 3-4, and 70% in weeks 5-6 for both lower- and upper-body exercises.
Participants in the control group will perform the identical BFR exercise protocol as the intervention group. However, IMT will be delivered at 2% of MIP, which is considered a sham condition and has not been shown to improve respiratory muscle function
Eligibility Criteria
You may qualify if:
- Community-dwelling adults aged 65 years and older who are classified as at least "vulnerable" using the Clinical Frailty Scale (score ≥4).
- Participants must have no cognitive impairment and be able to follow commands, as assessed by the Mini-Mental State Examination (MMSE).
You may not qualify if:
- (1) are unable to participate in exercise (e.g., due to severe musculoskeletal disorders)
- (2) have high-risk factors for exercise, such as uncontrolled hypertension (\>150 mmHg systolic blood pressure (SBP) / \>90 mmHg diastolic blood pressure (DBP), coagulation disorders, and deep venous thrombosis
- (3) have hematological disorders or are using hematology related-medications
- (4) have significant comorbidities, including a history of stroke, diabetes with severe complications, or cardiovascular diseases
- (5) chronic lung conditions (e.g., obstructive pulmonary disease, asthma), and
- (6) have participated in a structured exercise training program within the past 3 months at a frequency exceeding three sessions per week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei Medical Universitylead
- National Taiwan Universitycollaborator
- The University of Texas at Austincollaborator
Study Sites (1)
Taipei Medical University
Taipei, 11031, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- We will implement a double-masking protocol, ensuring that participants and outcome assessors are all blinded to group assignments. Additionally, group assignments will also be masked from the data analyzer to minimize potential bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 23, 2026
First Posted
May 7, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share